{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:11:53Z","timestamp":1788412313185,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0637-z","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T01:25:15Z","timestamp":1427160315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Post-marketing surveillance of anti-malarial medicines used in Malawi"],"prefix":"10.1186","volume":"14","author":[{"given":"Ibrahim","family":"Chikowe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas","family":"Osei-Safo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry JEK","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y","family":"Konadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Addae-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"637_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4997\/JRCPE.2010.216","volume":"40","author":"AR Butler","year":"2010","unstructured":"Butler AR, Khan S, Ferguson E. A brief history of malaria chemotherapy. J R Coll Physicians Edinb. 2010;40:172\u20137.","journal-title":"J R Coll Physicians Edinb"},{"key":"637_CR2","volume-title":"World Malaria Report 2014","author":"WHO","year":"2014","unstructured":"WHO. World Malaria Report 2014. Geneva, Switzerland: World Health Organization; 2014."},{"key":"637_CR3","volume-title":"NMCP: Malaria strategic plan 2011\u20132015; towards universal access","author":"NMC Programme","year":"2011","unstructured":"Programme NMC. NMCP: Malaria strategic plan 2011\u20132015; towards universal access. Lilongwe, Malawi: Ministry of Health; 2011."},{"key":"637_CR4","first-page":"74","volume":"45","author":"M Ettling","year":"1994","unstructured":"Ettling M, McFarland DA, Schultz LJ, Chitsulo L. Economic impact of malaria in Malawian households. Trop Med Parasitol. 1994;45:74\u20139.","journal-title":"Trop Med Parasitol"},{"key":"637_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro2385","volume":"8","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010;8:272\u201380.","journal-title":"Nat Rev Microbiol"},{"key":"637_CR6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/bmj.324.7341.800","volume":"324","author":"PN Newton","year":"2002","unstructured":"Newton PN, White NJ, Rozendaal JA, Green MD. Murder by fake medicines. BMJ. 2002;324:800\u20131.","journal-title":"BMJ"},{"key":"637_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","volume":"12","author":"GML Nayyar","year":"2012","unstructured":"Nayyar GML, Breman JG, Newton PN, Herrington J. Poor-quality antimalarial, medicines in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012;12:488\u201396.","journal-title":"Lancet Infect Dis"},{"key":"637_CR8","unstructured":"Maponga C, Ondari C. The quality of antimalarials; a study in selected African countries. World Health Organization (WHO) Department of Essential Medicines and Medicines. WHO\/EDM\/PAR\/2003.4; 2003 [http:\/\/apps.who.int\/medicinedocs\/pdf\/s4901e\/s4901e.pdf]"},{"key":"637_CR9","unstructured":"Staedke S: Medicine safety and quality. London School of Hygiene and Tropical Medicine; Uganda Malaria Surveillance Project. ACT Consortium; 2009. [http:\/\/www.actconsortium.org\/data\/files\/actc_safety_and_quality__overview.pdf]"},{"key":"637_CR10","unstructured":"Strengthening Pharmaceutical Systems (SPS) Program: Safety of medicines in sub-Saharan Africa: assessment of pharmacovigilance systems and their performance. US Agency for International Development by the Strengthening Pharmaceutical Systems (SPS) Program. Arlington, VA: Management Sciences for Health; 2011. [http:\/\/apps.who.int\/medicinedocs\/en\/d\/Js19152en\/]"},{"key":"637_CR11","unstructured":"World Health Organization: The International pharmacopoeia (including first, second and third supplements). 4th Edition, Version 2; Online, Geneva; 2013. [http:\/\/apps.who.int\/phint\/en\/p\/about\/]"},{"key":"637_CR12","volume-title":"The International pharmacopoeia 4th Edition, Version 2; CD-ROM, Geneva","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. The International pharmacopoeia 4th Edition, Version 2; CD-ROM, Geneva. Antwerp, Belgium: Human Info NGO\/WIT; 2006."},{"key":"637_CR13","unstructured":"World Health Organization, BTD. Basic tests for medicines: pharmaceutical substances, medicinal plant materials and dosage form; 1998. [http:\/\/whqlibdoc.who.int\/publications\/1998\/9241545135.pdf]"},{"key":"637_CR14","volume-title":"New basic tests for antimalarials","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. New basic tests for antimalarials. CH-1211 Geneva 27, Switzerland: Quality Assurance and Safety: Medicines (QSM), Department of Essential Medicines and Medicines Policy (EDM), World Health Organization Working Document QAS\/06.159; 2006."},{"key":"637_CR15","unstructured":"WHO: Basic tests for pharmaceutical dosage forms. Geneva; World Health Organization, 1991. [http:\/\/apps.who.int\/medicinedocs\/pdf\/h1794e\/h1794e.pdf]"},{"key":"637_CR16","unstructured":"Osei-Safo D, Harrison JJEK, Addae-Mensah I: Validation and application of quality assurance methods developed for artemisinin-based antimalarial medicines to assess the quality of a selection of such medicines distributed in Accra, Ghana. African Journal of Pharmaceutical Sciences and Pharmacy 2010, 1: 1\u201325. Retrieved from [http:\/\/www.ajpspjournal.com\/article\/view\/6206]"},{"key":"637_CR17","doi-asserted-by":"crossref","unstructured":"Osei-Safo D, Agbonon A, Konadu DY, Harrison JJEK, Edoh M, Gordon A, Gbeassor M, Addae-Mensah I: Evaluation of the quality of artemisinin-based antimalarial medicines distributed in Ghana and Togo. Malar Res Treat 2014, Article ID 806416, 12 pages. [http:\/\/www.hindawi.com\/journals\/mrt\/2014\/806416\/]","DOI":"10.1155\/2014\/806416"},{"key":"637_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1134\/S1061934810050126","volume":"65","author":"SS Ranher","year":"2010","unstructured":"Ranher SS, Gandhi SV, Kadukar SS, Ranjane PN. A validated HPLC method for determination of artesunate in bulk and tablet formulation. J Anal Chem. 2010;65:507\u201310.","journal-title":"J Anal Chem"},{"key":"637_CR19","first-page":"201","volume":"2","author":"A Arun","year":"2011","unstructured":"Arun A, Smith AA. Simultaneous HPLC-UV method for the estimation of artemether and lumefantrine in tablet dosage form. Int J Pharma Biomed Res. 2011;2:201\u20135. ISSN No.: 0976\u20130350.","journal-title":"Int J Pharma Biomed Res"},{"key":"637_CR20","first-page":"1458","volume-title":"Monographs of quinine sulphate and quinine sulphate tablets","author":"The United States Pharmacopoeia USP NF 24","year":"2006","unstructured":"The United States Pharmacopoeia USP NF 24. Monographs of quinine sulphate and quinine sulphate tablets. Rockville: United States Pharmacopoeia Convention; 2006. p. 1458\u201360."},{"key":"637_CR21","unstructured":"WHO expert committee. Sulphadoxine and pyrimethamine tablets. Adopted text for addition to The International Pharmacopoeia. World Health Organization Working document QAS\/07.218\/FINAL; 2011. [http:\/\/www.who.int\/medicines\/publications\/pharmacopoeia\/Sulfadox-Pyrimeth-tab-QAS07-218FINAL.pdf]"},{"key":"637_CR22","volume-title":"Counterfeit drugs. Guidelines for the development of measures to combat counterfeit drugs","author":"World Health Organization","year":"1999","unstructured":"World Health Organization. Counterfeit drugs. Guidelines for the development of measures to combat counterfeit drugs. Geneva: World Health Organization; 1999. WHO\/EDM\/QSM\/99.1."},{"key":"637_CR23","doi-asserted-by":"publisher","first-page":"e2132","DOI":"10.1371\/journal.pone.0002132","volume":"3","author":"R Bate","year":"2008","unstructured":"Bate R, Coticelli P, Tren R, Attaran A. Antimalarial medicine quality in the most severely malarious parts of Africa \u2013 A six country study. PLoS One. 2008;3:e2132.","journal-title":"PLoS One"},{"key":"637_CR24","unstructured":"WHO QAMSA. Survey of the quality of selected antimalarial medicines circulating in six countries of sub-Saharan Africa. Geneva: World Health Organization Quality Assurance and Safety; Essential Medicines and pharmaceutical Policies, WHO\/EMP\/QSM\/2011.1; 2011. [http:\/\/www.who.int\/medicines\/publications\/WHO_QAMSA_report.pdf]"},{"key":"637_CR25","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1365-3156.2008.02106.x","volume":"13","author":"JM Caudron","year":"2008","unstructured":"Caudron JM, Ford N, Henkens M, Mac\u00e9 C, Kiddle-Monroe R, Pinel J. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008;13:1062\u201372.","journal-title":"Trop Med Int Health"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0637-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-015-0637-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0637-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0637-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:34:31Z","timestamp":1630575271000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-015-0637-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0637-z","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"31 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"127"}}